Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
TELO holding history
Telomir Pharmaceuticals, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TELO overviewAll 13F holders of TELOFull Q2 2026 holdings
- Shares (Q2 2026)
- 5
- Value
- $6
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5 | $6 | <0.1% | +5 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −334−100.0% | Sold out | Holders |
| Q3 2025 | 334 | $464 | <0.1% | −25,073−98.7% | Reduced | Holders |
| Q2 2025 | 25,407 | $31.8K | <0.1% | −3,616−12.5% | Reduced | Holders |
| Q1 2025 | 29,023 | $93.7K | <0.1% | −11,198−27.8% | Reduced | Holders |
| Q4 2024 | 40,221 | $165.7K | <0.1% | +28,767+251.2% | Added | Holders |
| Q3 2024 | 11,454 | $73.5K | <0.1% | +6,255+120.3% | Added | Holders |
| Q2 2024 | 5,199 | $25.0K | <0.1% | +5,199 | New | Holders |